Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:GWPH

GW Pharmaceuticals (GWPH) Stock Price, News & Analysis

GW Pharmaceuticals logo

About GW Pharmaceuticals Stock (NASDAQ:GWPH)

Advanced Chart
Remove Ads

Key Stats

Today's Range
$218.96
$218.96
50-Day Range
$216.90
$219.28
52-Week Range
$87.07
$219.57
Volume
N/A
Average Volume
899,771 shs
Market Capitalization
$6.86 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

GW Pharmaceuticals plc, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform in various disease areas. Its lead product is Epidiolex, an oral medicine for the treatment of seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex. The company also develops and markets Sativex for the treatment of spasticity due to multiple sclerosis. In addition, it develops various product candidates for the treatment of schizophrenia, autism spectrum disorder, neuropsychiatric symptom, and neonatal hypoxic ischemic encephalopathy. It primarily operates in Europe, the United Kingdom, the United States, and internationally. GW Pharmaceuticals plc was founded in 1998 and is based in Cambridge, the United Kingdom.

Remove Ads
Receive GWPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GW Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

GWPH Stock News Headlines

Partner with Elon Musk on Project Colossus… Before May 1st
Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you… To partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500.
GWPRF Historical Data
George Washington University
GW Pharmaceuticals PLC (GWPRF)
See More Headlines

GWPH Stock Analysis - Frequently Asked Questions

GW Pharmaceuticals plc (NASDAQ:GWPH) released its quarterly earnings data on Tuesday, November, 3rd. The biopharmaceutical company reported ($0.36) EPS for the quarter, topping analysts' consensus estimates of ($0.63) by $0.27. The firm's revenue for the quarter was up 50.7% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that GW Pharmaceuticals investors own include NVIDIA (NVDA), Canopy Growth (CGC), Meta Platforms (META), Tesla (TSLA), Netflix (NFLX), Advanced Micro Devices (AMD) and Alibaba Group (BABA).

Company Calendar

Last Earnings
11/03/2020
Today
4/01/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:GWPH
Fax
N/A
Employees
1,161
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-9,020,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$311.33 million
Cash Flow
$0.01 per share
Price / Cash Flow
18,588.22
Book Value
$23.48 per share
Price / Book
9.33

Miscellaneous

Free Float
N/A
Market Cap
$6.86 billion
Optionable
Optionable
Beta
2.15

Social Links

7 Top Nuclear Stocks To Buy Now Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:GWPH) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners